Search Results - Thamir Alshammari

Are drug safety measures harmonized? A real-world evidence from three regulatory authorities by Sadeem Alelayan, Leena Al-Sheikh, Rana Almotawa, Hadeel Alkofide, Thamir Alshammari

Connect to this object online.

Corrigendum to "Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia" [Saudi Pharm. J. 22(5) (2014) 411-418] by Mansour Adam Mahmoud, Yazed Alsowaida, Thamir Alshammari, Tahir Mehmood Khan, Alian Alrasheedy, Mohamad Azmi Hasssali, Hisham Aljadhey

Connect to this object online.

Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia by Mansour Almetwazi, Monira Alwhaibi, Bander Balkhi, Hissah Almohaini, Haya Alturki, Tariq Alhawassi, Sondus Ata, Nasser AlQahtani, Mansour Mahmoud, Thamir Alshammari

Connect to this object online.

The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section by Waleed Alhazzani, Mohammed Alshahrani, Fayez Alshamsi, Ohoud Aljuhani, Khalid Eljaaly, Samaher Hashim, Rakan Alqahtani, Doaa Alsaleh, Zainab Al Duhailib, Haifa Algethamy, Tariq Al-Musawi, Thamir Alshammari, Abdullah Alqarni, Danya Khoujah, Wail Tashkandi, Talal Dahhan, Najla Almutairi, Haleema A. Alserehi, Maytha Al-Yahya, Bandar Al-Judaibi, Yaseen M. Arabi, Jameel Abualenain, Jawaher M. Alotaibi, Ali Al bshabshe, Reham Alharbi, Fahad Al-Hameed, Alyaa Elhazmi, Reem S. Almaghrabi, Fatma Almaghlouth, Malak Abedalthagafi, Noor Al Khathlan, Faisal A. Al-Suwaidan, Reem F. Bunyan, Bandar Baw, Ghassan Alghamdi, Manal Al Hazmi, Yasser Mandourah, Abdullah Assiri, Mushira Enani, Maha Alawi, Reem Aljindan, Ahmed Aljabbary, Abdullah Alrbiaan, Fahd Algurashi, Abdulmohsen Alsaawi, Thamer H. Alenazi, Mohammed A. Alsultan, Saleh A. Alqahtani, Ziad Memish, Jaffar A. Al-Tawfiq, Ahmed Al-jedai

Connect to this object online.